2018-02826. Notice of Closed Meeting  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

    The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of Start Printed Page 6177the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP); Funding Opportunity Announcement (FOA), IP18-001, Reducing Disparities in Vaccination Coverage by Poverty Status Among Young Children and IP18-003, Understanding and Addressing the Disparity in Vaccination Coverage Among U.S. Adolescents Living in Rural versus Urban Areas.

    Dates: March 20, 2018 and March 21, 2018.

    Time: 10:00 a.m.-5:00 p.m. (EDT)

    Place: Teleconference, Centers for Disease Control and Prevention, Room 1080, 8 Corporate, Atlanta, GA 30329.

    Agenda: To review and evaluate grant applications.

    For Further Information Contact: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE, Mailstop E-60, Atlanta, Georgia 30333, (404) 718-8833, gca5@cdc.gov.

    The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

    Start Signature

    Elaine L. Baker,

    Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.

    End Signature End Preamble

    [FR Doc. 2018-02826 Filed 2-12-18; 8:45 am]

    BILLING CODE 4163-18-P

Document Information

Published:
02/13/2018
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Document Number:
2018-02826
Dates:
March 20, 2018 and March 21, 2018.
Pages:
6176-6177 (2 pages)
PDF File:
2018-02826.pdf